Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2024; 14(5): 112-119


Cytotoxic constituents of Cymbidium tracyanum L.Castle

Nonthalert Lertnitikul, Rutt Suttisri, Khin Lay Sein, Suree Jianmongkol, Cherdsak Boonyong, Witchuda Thanakijcharoenpath.




Abstract

Three phenanthrene derivatives, cymbisamoquinone (1), calanquinone B (6), and 3,7-dihydroxy-2,4,6- trimethoxyphenanthrene (2), and two bibenzyls, Tristin (3) and gigantic (4), together with the lignan (+)-pinoresinol (5), were isolated from the whole plants of Cymbidium tracyanum L.Castle (Orchidaceae). Their structures were determined through spectroscopic analysis as well as a comparison of the spectral data with literature values. The phytochemical constituents of this plant have been reported for the first time. All isolated compounds were evaluated for in vitro cytotoxic activity against human colon (Caco-2) and breast (MCF-7) cancer cell lines, doxorubicin-resistant (MCF-7/DOX) and mitoxantrone-resistant (MCF-7/MX) MCF-7 sublines, together with normal human fibroblast (NIH/3T3) cell line. Among the isolated compounds, 1 exhibited the strongest and relatively selective activity on MCF-7/DOX cells. The results obtained from the molecular docking study suggested that the cytotoxicity of 1 on MCF-7/DOX cells was possibly due to the induction of apoptosis via suppression of the cell survival systems mediated by the mitogen-activated protein kinases and protein kinase B/glycogen synthase kinase-3β/nuclear factor erythroid 2-related factor 2 signalling pathways.

Key words: Cymbidium tracyanum, cymbisamoquinone, phenanthrenequinones, phenanthrenes, bibenzyls, cytotoxic activity






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.